NeuPath Health Inc.

Equities

NPTH

CA64133P1009

Healthcare Facilities & Services

Delayed Toronto S.E. Other stock markets 10:48:29 2024-06-04 am EDT			5-day change	1st Jan Change
0.205 ^CAD	+5.13%		+5.13%	+10.81%

May. 16	NeuPath Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 15	NeuPath Health Narrows Q4 Loss, Revenue Rises	MT

NeuPath Health Inc. Appoints Joseph Walewicz as Interim Chief Executive Officer

September 30, 2022 at 07:30 am EDT

NeuPath Health Inc. announced that Joseph Walewicz has been appointed as Interim Chief Executive Officer to execute the current growth strategy, a continuation of the work that Dianne and Joe had already been conducting together.

Latest news about NeuPath Health Inc.

NeuPath Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 16	CI
NeuPath Health Narrows Q4 Loss, Revenue Rises	Mar. 15	MT
NeuPath Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 15	CI
NeuPath Health Inc. acquired Assets of The London Spine Centre from The London Spine Centre.	Jan. 14	CI
NeuPath Health Reports Q3 2023 Revenue of $16.1 Million, up 6%	Nov. 16	MT
NeuPath Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 16	CI
NeuPath Health Inc. Announces Successful Closing of Updated Credit Facility	Nov. 13	CI
NeuPath Health Closes Sale of Corporate-Owned Medical Facility	23-09-05	MT
An unknown buyer completed the acquisition of London medical facility, Ontario from NeuPath Health Inc..	23-09-04	CI
NeuPath Health Swings to Profit in Q2, Revenue Grows	23-08-17	MT
NeuPath Health Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-17	CI
NeuPath Health Inc. Brief: Record Q2 Total Revenue of $17.1 million	23-08-17	MT
NeuPath Health Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-25	CI
NeuPath Health Closes Brokered Private Placement	23-05-02	MT
NeuPath Health Inc. announced that it has received CAD 1.453 million in funding	23-05-01	CI
NeuPath Health Inc. announced that it expects to receive CAD 1.4 million in funding	23-04-10	CI
NeuPath Health Inc. Brief: Edging Lower Although Says Delivered Record Quarterly Revenues and Opened New Fluoroscopy Suite to Patients	23-03-30	MT
NeuPath Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
NeuPath Health Inc. Auditor Raises 'Going Concern' Doubt	23-03-29	CI
NeuPath Health Agrees to Sell Corporate-owned Medical Facility	23-03-15	MT
An unknown buyer agreed to acquire London medical facility, Ontario from NeuPath Health Inc..	23-03-14	CI
NeuPath Health Q3 Loss $1.14 Million Vs Loss $0.66 Million Year Ago; Revenue Flat at $15.2 Million	22-11-17	MT
NeuPath Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-17	CI
NeuPath Health Inc Announces Board Changes	22-10-19	CI
NeuPath Health Executive Chair Dianne Carmichael Steps Down, Names Interim CEO; Suspends Software Development	22-09-30	MT

Chart NeuPath Health Inc.

Duration

Period

More charts

Company Profile

NeuPath Health Inc. operates a network of healthcare clinics and related businesses focused on improved access to care and outcomes for patients by leveraging treatments and delivering patient-centered multidisciplinary care. The Company operates a network of medical clinics in Ontario and Alberta that provide comprehensive assessments and rehabilitation services to clients with chronic pain, musculoskeletal/back injuries, sports related injuries and concussions. It provides workplace health services and independent medical assessments to employers and disability insurers through a national network of healthcare providers, as well as contract research services to pharmaceutical and biotechnology companies. The Company's health care providers cover a range of specialties, which include physiatrists, neurologists, anesthesiologists, general practitioners with specialized training in chronic pain, as well as medication management physicians, athletic therapists, and nurses.

Sector

Healthcare Facilities & Services

Calendar

2024-06-12 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

0.205 CAD

Average target price

0.5 CAD

Spread / Average Target

+143.90%

Consensus

Annual profits - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

	1st Jan change	Capi.
NEUPATH HEALTH INC.	+10.81%	8.43M
HCA HEALTHCARE, INC.	+24.01%	86.96B
CVS HEALTH CORPORATION	-23.36%	75.65B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+0.49%	26.97B
FRESENIUS SE & CO. KGAA	+5.59%	17.89B
LABCORP HOLDINGS INC.	-12.54%	16.58B
QUEST DIAGNOSTICS INCORPORATED	+3.46%	15.73B
NATERA, INC.	+78.80%	13.01B
TENET HEALTHCARE CORPORATION	+80.18%	12.92B
DAVITA INC.	+37.69%	12.57B

Other Healthcare Facilities & Services